Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2519 Views
-
Last post by NHE
-
- 0 Replies
- 1255 Views
-
Last post by frodo
-
- 0 Replies
- 1131 Views
-
Last post by NHE
-
- 0 Replies
- 1349 Views
-
Last post by frodo
-
- 0 Replies
- 1484 Views
-
Last post by NHE
-
- 0 Replies
- 1219 Views
-
Last post by frodo
-
- 0 Replies
- 1550 Views
-
Last post by NHE
-
- 0 Replies
- 1844 Views
-
Last post by DIM
-
- 0 Replies
- 1474 Views
-
Last post by NHE